256 related articles for article (PubMed ID: 31194884)
1. Treatment of symptomatic adenomyosis with the levonorgestrel-releasing intrauterine system.
Li L; Leng J; Jia S; Lang J
Int J Gynaecol Obstet; 2019 Sep; 146(3):357-363. PubMed ID: 31194884
[TBL] [Abstract][Full Text] [Related]
2. [A prospective study on the effects of levonorgestrel-releasing intrauterine system for adenomyosis with menorrhagia].
Li L; Leng JH; Shi JH; Zhang JJ; Jia SZ; Li XY; Dai Y; Zhang JR; Li T; Xu XX; Liu ZZ; You SS; Chang XY; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2016 Jun; 51(6):424-30. PubMed ID: 27356477
[TBL] [Abstract][Full Text] [Related]
3. [A prospective cohort study on effects of levonorgestrel-releasing intrauterine system for adenomyosis with severe dysmenorrhea].
Li L; Leng JH; Dai Y; Zhang JJ; Jia SZ; Li XY; Shi JH; Zhang JR; Li T; Xu XX; Liu ZZ; You SS; Chang XY; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2016 May; 51(5):345-51. PubMed ID: 27256441
[TBL] [Abstract][Full Text] [Related]
4. Clinical experiences of the levonorgestrel-releasing intrauterine system in patients with large symptomatic adenomyosis.
Park DS; Kim ML; Song T; Yun BS; Kim MK; Jun HS; Seong SJ
Taiwan J Obstet Gynecol; 2015 Aug; 54(4):412-5. PubMed ID: 26384061
[TBL] [Abstract][Full Text] [Related]
5. The role of levonorgestrel intra-uterine system in the management of adenomyosis: A systematic review and meta-analysis of prospective studies.
Abbas AM; Samy A; Atwa K; Ghoneim HM; Lotfy M; Saber Mohammed H; Abdellah AM; El Bahie AM; Aboelroose AA; El Gedawy AM; Mostafa M; Elsenity MA; Samy M; Safwat S; Abdelrahman RM; Salah El Din AS; Badran E; Abdelkader AM; Abdallah A
Acta Obstet Gynecol Scand; 2020 May; 99(5):571-581. PubMed ID: 31889294
[TBL] [Abstract][Full Text] [Related]
6. Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis.
Kelekci S; Kelekci KH; Yilmaz B
Contraception; 2012 Nov; 86(5):458-63. PubMed ID: 22832203
[TBL] [Abstract][Full Text] [Related]
7. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis.
Sheng J; Zhang WY; Zhang JP; Lu D
Contraception; 2009 Mar; 79(3):189-93. PubMed ID: 19185671
[TBL] [Abstract][Full Text] [Related]
8. Postoperative maintenance levonorgestrel-releasing intrauterine system for symptomatic uterine adenomyoma.
Lin CJ; Hsu TF; Chang YH; Huang BS; Jiang LY; Wang PH; Chen YJ
Taiwan J Obstet Gynecol; 2018 Feb; 57(1):47-51. PubMed ID: 29458902
[TBL] [Abstract][Full Text] [Related]
9. [Changes of menstruation patterns and adverse effects during the treatment of LNG-IUS for symptomatic adenomyosis].
Li L; Leng JH; Zhang JJ; Jia SZ; Li XY; Shi JH; Dai Y; Zhang JR; Li T; Xu XX; Liu ZZ; You SS; Chang XY; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2016 Sep; 51(9):657-662. PubMed ID: 27671045
[No Abstract] [Full Text] [Related]
10. Levonorgestrel-Releasing Intrauterine System Improves Menorrhagia-Related Quality of Life in Patients with Symptomatic Adenomyosis.
Ishizawa C; Hirota Y; Iida R; Kaku T; Hirata T; Fukui Y; Omura E; Akaeda S; Hiraoka T; Matsuo M; Osuga Y
Reprod Sci; 2023 Mar; 30(3):966-973. PubMed ID: 36071343
[TBL] [Abstract][Full Text] [Related]
11. The treatment with Levonorgestrel Releasing Intrauterine System (LNG-IUS) in patients affected by menometrorrhagia, dysmenorrhea and adenomimyois: clinical and ultrasonographic reports.
Costanzi F; De Marco MP; Colombrino C; Ciancia M; Torcia F; Ruscito I; Bellati F; Frega A; Cozza G; Caserta D
Eur Rev Med Pharmacol Sci; 2021 May; 25(9):3432-3439. PubMed ID: 34002816
[TBL] [Abstract][Full Text] [Related]
12. Role of levonorgestrel-releasing intrauterine system in dysmenorrhea due to adenomyosis and the influence on ovarian function.
Ji F; Yang XH; Ai Xing Zi AL; Ha Ni Ke Zi TX; He Y; Ding Y
Clin Exp Obstet Gynecol; 2014; 41(6):677-80. PubMed ID: 25566593
[TBL] [Abstract][Full Text] [Related]
13. Levonorgestrel-releasing intrauterine system versus a low-dose combined oral contraceptive for treatment of adenomyotic uteri: a randomized clinical trial.
Shaaban OM; Ali MK; Sabra AM; Abd El Aal DE
Contraception; 2015 Oct; 92(4):301-7. PubMed ID: 26071673
[TBL] [Abstract][Full Text] [Related]
14. [A prospective cohort study on the impact of placement timing of LNG-IUS for adenomyosis].
Li L; Leng JH; Zhang JJ; Jia SZ; Li XY; Shi JH; Liu ZZ; You SS; Chang XY; Lang YH
Zhonghua Yi Xue Za Zhi; 2016 Aug; 96(30):2415-20. PubMed ID: 27545034
[TBL] [Abstract][Full Text] [Related]
15. [Effects of levonorgestrel-releasing intrauterine system on pain and recurrence associated with endometriosis and adenomyosis].
Deng S; Lang JH; Leng JH; Liu ZF; Sun DW; Zhu L
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):664-8. PubMed ID: 17199919
[TBL] [Abstract][Full Text] [Related]
16. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Lethaby AE; Cooke I; Rees M
Cochrane Database Syst Rev; 2005 Oct; (4):CD002126. PubMed ID: 16235297
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound-guided transvaginal radiofrequency ablation combined with levonorgestrel-releasing intrauterine system for symptomatic uterine adenomyosis treatment.
Hai N; Hou Q; Guo R
Int J Hyperthermia; 2021; 38(1):65-69. PubMed ID: 33472465
[TBL] [Abstract][Full Text] [Related]
18. Feasibility and Effectiveness of Hysteroscopic Suture Fixation of the Levonorgestrel-Releasing Intrauterine System in the Treatment of Adenomyosis.
Lv N; Guo J; Yuan Q; Shen S; Chen Q; Tong J
J Minim Invasive Gynecol; 2024 Jan; 31(1):57-63. PubMed ID: 37838016
[TBL] [Abstract][Full Text] [Related]
19. Use of a levonorgestrel 52-mg intrauterine system in the control of abnormal uterine bleeding in women with inherited bleeding disorders.
Campos RR; Baêta T; Silva-Filho A; Rezende SM; Rocha ALL
Contraception; 2020 Oct; 102(4):254-258. PubMed ID: 32470465
[TBL] [Abstract][Full Text] [Related]
20. Real-world outcomes of the levonorgestrel-releasing intrauterine system for heavy menstrual bleeding or dysmenorrhea in Japanese patients: A prospective observational study (J-MIRAI).
Harada T; Ota I; Kitawaki J; Momoeda M; Maeda N; Akira S; Umeyama M; Sunaya T; Hirano K
Contraception; 2022 Dec; 116():22-28. PubMed ID: 36057322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
